Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 3, 2012, Pages 290-293

  Staehler, Michael ^a   Haseke, Nicolas ^a   Stadler, Thomas ^a   Nuhn, Philipp ^a   Roosen, Alexander ^a   Stief, Christian G ^a   Wilkowski, Ralf ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Klinik Bad Trissl   (Germany)

Author keywords

Combination therapy; Complete remission; Radiotherapy; Renal cell cancer; Sunitinib

Indexed keywords

PHOSPHOTRANSFERASE; SUNITINIB;

ADULT; AGED; ANOREXIA; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DYSPHAGIA; ENZYME INHIBITION; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; KIDNEY CANCER; KIDNEY METASTASIS; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; NAUSEA; NEUROLOGICAL COMPLICATION; PAIN; PERIPHERAL EDEMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROPERITONEAL CANCER; SKIN TOXICITY; SPINAL CORD METASTASIS; SYSTEMIC THERAPY; TREATMENT FAILURE; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; DOSE FRACTIONATION; FEMALE; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PYRROLES; RADIOTHERAPY; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860286851     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.02.006     Document Type: Article

References (13)

1. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site [database on the Internet] 2008.
2. Motzer R.J., Hutson T.E., Tomczak P., et al. Sunitinib vs. interferon α in metastatic renal-cell carcinoma. N Engl J Med 2007, 356:115-124.
3. Cho J., Kim G.E., Rha K.H., et al. Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: A case report. J Korean Med Sci 2008, 23:740-743.
4. DiBiase S.J., Valicenti R.K., Schultz D., et al. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: Support for dose escalation based on a biological model. J Urol 1997, 158(3 Pt 1):746-749.
5. Lee J., Hodgson D., Chow E., et al. A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer 2005, 104:1894-1900.
6. Ning S., Trisler K., Wessels B.W., et al. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer 1997, 80(12 Suppl):2519-2528.
7. Brinkmann O.A., Bruns F., Gosheger G., et al. Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation. World J Urol 2005, 23:185-190.
8. Zingg D., Riesterer O., Fabbro D., et al. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells. Cancer Res 2004, 64:5398-5406.
9. Dent P., Reardon D.B., Park J.S., et al. Radiation-induced release of transforming growth factor α activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol Biol Cell 1999, 10:2493-2506.
10. Kasibhatla M., Steinberg P., Meyer J., et al. Radiation therapy and sorafenib: Clinical data and rationale for the combination in metastatic renal cell carcinoma. Clin Genitourin Cancer 2007, 5:291-294.
11. Peters N.A., Richel D.J., Verhoeff J.J., et al. Bowel perforation after radiotherapy in a patient receiving sorafenib. J Clin Oncol 2008, 26:2405-2406.
12. Gay H.A., Cavalieri R., Allison R.R., et al. Complete response in a cutaneous facial metastatic nodule from renal cell carcinoma after hypofractionated radiotherapy. Dermatol Online J 2007, 13:6.
13. Taussky D., Soulieres D. Hypofractionated radiotherapy with concomitant sunitinib-is there a radiosensitizing effect?. Can J Urol 2009, 16:4599-4600.